bilastine
Based on safety finding collected during the clinical development, no important identified risks were detected, whereas the following potential safety concerns were highlighted for a close monitoring during the post-marketing surveillance: Important potential risks 1. Dizziness 2. Headache 3. Somnolence 4. Electrocardiogram QT prolonged Certain medications can also cause QT prolongation, including some belonging to the following groups: antibiotics antifungals diuretics antidepressants antipsychotics antiarrhythmics Other Diagnostic Factors: Additional factors that can support a diagnosis of LQTS include: Dizziness, angina, fatigue, oliguria, muscle weakness, tetany, numbness, Chvostek's sign, Trousseau's sign, cold extremities, hypotension, and confusion.